Committee advances labeling bill for menstrual products amid enforcement debate

Delegate Seibold presented HB998, a bill requiring that any menstrual supply sold in Virginia include a label listing all ingredients in the product (confidential ingredients could remain protected). Sponsors argued the bill addresses consumer safety concerns after detection of PFAS (so‑called "forever chemicals") in some products.

Senator Peake questioned whether moving enforcement into the Virginia Consumer Protection Act would expose manufacturers to treble damages and attorney's fees. Committee counsel explained that treating a violation as a prohibited practice under the Consumer Protection Act would place the claim within that statutory enforcement framework and could change available civil remedies; counsel offered to clarify whether attorney's fees would be included under the amended mechanism.

Industry representative Matt Welles Devantis of Global Cellulose Fibers said his company supports the committee reporting the bill and praised stakeholder engagement but sought clarity on certain details. After debate and amendment, the committee reported HB998 as amended (Ayes 9, Noes 3).

Why it matters: The bill would increase consumer disclosure about product ingredients and respond to public health concerns about PFAS. Amending enforcement to the Consumer Protection Act drew concern from some committee members about the potential for expanded civil liability and damages.

What’s next: HB998 was reported as amended and will continue through the legislative process; counsel indicated the committee will follow up on specifics of enforcement provisions before final passage.

Provenance: Presentation, counsel Q&A, industry comment and the roll call are recorded in SEG 1063–1250, with the vote recorded SEG 1246–1248.